Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...

Gain insights into Recursion Pharmaceuticals' Q4 2024 earnings call. Discover clinical advancements, key partnerships, and strategic plans for 2025.

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

The current rate for a 30-second spot during the 2025 telecast ranges between $1.7 million and $2.3 million, an individual ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

Enveda gets support from Sanofi to advance AI-driven drug discovery to clinical trials: Boulder, Colorado Friday, February 28, 2025, 16:00 Hrs [IST] Enveda, a leading biotechnolog ...

Multibagger stock Vantage Knowledge Academy Limited hits upper circuit after setting record date for 2:1 bonus shares. The ...

Barclays analyst Emily Field maintained a Sell rating on Galapagos (0JXZ – Research Report) today and set a price target of €22.00. The ...

Home First Finance Company India Ltd, Sanofi India Ltd, Valor Estate Ltd and Jindal Saw Ltd are among the other gainers in the BSE's 'A' group today, 28 February 2025.